SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

被引：0
|
作者：
Yehong Bin
Dong Lan
Wenguang Bao
Haiyan Yang
Shengsheng Zhou
Fengxiang Huang
Man Wang
Zhigang Peng
机构：
[1] the First Affiliated Hospital of Guangxi Medical University,Department of Oncology
来源：
Trials | / 23卷
关键词：
Advanced gastric cancer; Malignant ascites; Intraperitoneal infusion of chemotherapy; First-line chemotherapy; Docetaxel; S-1; Oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Sung Yong Oh
    Hyuk-Chan Kwon
    Sang-Ho Jeong
    Young-Tae Joo
    Young-Joon Lee
    Su hee Cho
    Myoung Hee Kang
    Se-il Go
    Gyeong-won Lee
    Hoon gu Kim
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 350 - 356
  • [22] A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
    Oh, Sung Yong
    Kwon, Hyuk-Chan
    Jeong, Sang-Ho
    Joo, Young-Tae
    Lee, Young-Joon
    Cho, Su Hee
    Kang, Myoung Hee
    Go, Se-il
    Lee, Gyeong-won
    Kim, Hoon Gu
    Kang, Jung Hun
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 350 - 356
  • [23] Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer
    Bilici, Ahmet
    Selcukbiricik, Fatih
    Demir, Nazan
    Ustaalioglu, Bala Basak Oven
    Dikilitas, Mustafa
    Yildiz, Ozcan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (20) : 8661 - 8666
  • [24] Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer
    Yoon-Koo Kang
    Min-Hee Ryu
    Changhoon Yoo
    Heung-Moon Chang
    Jeong Hwan Yook
    Sung Tae Oh
    Byung Sik Kim
    Tae Won Kim
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1435 - 1443
  • [25] Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial
    Xiao, Jian
    Chen, Yonghe
    Li, Wenyun
    Gong, Jiaying
    Zhou, Zhiyang
    Deng, Yanhong
    Wang, Lei
    Ren, Donglin
    Wang, Jianping
    Peng, Junsheng
    Lan, Ping
    MEDICAL ONCOLOGY, 2015, 32 (02)
  • [26] Dose-dense biweekly docetaxel combined with 5-fluorouracil as first-line treatment in advanced gastric cancer: a phase II trial
    Jian Xiao
    Yonghe Chen
    Wenyun Li
    Jiaying Gong
    Zhiyang Zhou
    Yanhong Deng
    Lei Wang
    Donglin Ren
    Jianping Wang
    Junsheng Peng
    Ping Lan
    Medical Oncology, 2015, 32
  • [27] Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer
    Kitayama, Joji
    Ishigami, Hironori
    Kaisaki, Shoichi
    Hidemura, Akio
    Kato, Masahiro
    Otani, Kensuke
    Kamei, Takao
    Soma, Daisuke
    Miyato, Hideyo
    Yamashita, Hiroharu
    Nagawa, Hirokazu
    ONCOLOGY, 2010, 78 (01) : 40 - 46
  • [28] Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study
    Deng, Ya-Ya
    Jiang, Ding-Yi
    Zhu, Peng-Fei
    Lu, Hongrui
    Liu, Qian
    Zhang, Xinyue
    Pan, Shuang-Yue
    Chen, Zhe-Ling
    Yang, Liu
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [29] FOLFOX-4 regimen as first-line chemotherapy in elderly patients with advanced gastric cancer: A safety study
    Nardi, M.
    Azzarello, D.
    Maisano, R.
    Del Medico, P.
    Giannicola, R.
    Raffaele, M.
    Zavettieri, M.
    Costarella, S.
    Falzea, A.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (01) : 85 - 89
  • [30] Docetaxel and S-1 as a First-line Treatment in Patients with Advanced or Recurrent Gastric Cancer
    Tsutani, Yasuhiro
    Ohara, Masahiro
    Suzuki, Takahisa
    Minami, Kazuhito
    Miyahara, Eiji
    Kameda, Akira
    Noso, Yoshihiro
    ANTICANCER RESEARCH, 2009, 29 (07) : 2775 - 2779
12345